Authors: RAI K ROSE E REVICKI D BROWN R REBLANDO J

Citation: K. Rai et al., CLINICAL AND HEALTH-STATUS ASSESSMENTS IN ANEMIC CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) PATIENTS TREATED WITH EPOETIN ALFA, European journal of cancer, 31A, 1995, pp. 232-232

Authors: REVICKI DA IRWIN D REBLANDO J SIMON GE

Citation: Da. Revicki et al., THE ACCURACY OF SELF-REPORTED DISABILITY DAYS, Medical care, 32(4), 1994, pp. 401-404

Authors: ROSE E RAI K REVICKI D BROWN R REBLANDO J

Citation: E. Rose et al., CLINICAL AND HEALTH-STATUS ASSESSMENTS IN ANEMIC CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) PATIENTS TREATED WITH EPOETIN-ALFA (EPO), Blood, 84(10), 1994, pp. 10000526-10000526

Authors: DELISSOVOY G ELIXHAUSER A LUCE BR WESCHLER J MOWERY P REBLANDO J SOLOMKIN J

Citation: G. Delissovoy et al., COST-ANALYSIS OF IMIPENEM-CILASTATIN VERSUS CLINDAMYCIN WITH TOBRAMYCIN IN THE TREATMENT OF ACUTE INTRAABDOMINAL INFECTION, PharmacoEconomics, 4(3), 1993, pp. 203-214

Authors: ELIXHAUSER A LUCE BR TAYLOR WR REBLANDO J

Citation: A. Elixhauser et al., HEALTH-CARE CBA CEA - AN UPDATE ON THE GROWTH AND COMPOSITION OF THE LITERATURE, Medical care, 31(7), 1993, pp. 101900001-101900011